![]() | Sexually Transmitted Diseases (STD) Syndromic Management (AIDSCAP/FHI, 1997, 54 p.) |
![]() | ![]() | (introduction...) |
![]() | ![]() | HOLOGRAPHIC OVERVIEW |
![]() | ![]() | INTRODUCTION |
![]() | ![]() | (introduction...) |
![]() | ![]() | HIV and STD Global Burden |
![]() | ![]() | Role of STD on HIV Transmission |
![]() | ![]() | STD SYNDROMIC MANAGEMENT |
![]() | ![]() | (introduction...) |
![]() | ![]() | Definition |
![]() | ![]() | Theoretical Foundation |
![]() | ![]() | Advantages and Disadvantages |
![]() | ![]() | Cost-Effectiveness |
![]() | ![]() | DESIGN OF STD FLOWCHARTS |
![]() | ![]() | (introduction...) |
![]() | ![]() | Common Flowcharts |
![]() | ![]() | (introduction...) |
![]() | ![]() | Urethral Discharge Syndrome in Men |
![]() | ![]() | Vaginal Discharge Syndrome in Women |
![]() | ![]() | Pelvic Inflammatory Disease: The Management of Lower Abdominal Pain |
![]() | ![]() | Genital Ulcer Disease |
![]() | ![]() | Validity Testing of a Flowchart: Sensitivity and Specificity |
![]() | ![]() | OTHER COMPONENTS OF COMPREHENSIVE STD CASE MANAGEMENT |
![]() | ![]() | (introduction...) |
![]() | ![]() | Partner Treatment |
![]() | ![]() | Health Education |
![]() | ![]() | Condom Distribution |
![]() | ![]() | Adding Strategies |
![]() | ![]() | Syphilis Screening and Treatment |
![]() | ![]() | Training |
![]() | ![]() | INTRODUCTION OF STD SYNDROMIC MANAGEMENT IN LAC |
![]() | ![]() | (introduction...) |
![]() | ![]() | Haiti |
![]() | ![]() | Jamaica |
![]() | ![]() | Brazil |
![]() | ![]() | Honduras |
![]() | ![]() | Dominican Republic |
![]() | ![]() | LESSONS LEARNED |
![]() | ![]() | (introduction...) |
![]() | ![]() | Building Consensus and Communication |
![]() | ![]() | Development and Implementation of STD Flowcharts |
![]() | ![]() | Improving Access to STD Care |
![]() | ![]() | Detecting Asymptomatic STDs |
![]() | ![]() | RECOMMENDATIONS |
![]() | ![]() | REFERENCES |
- A single, universally applicable model for STD flowcharts does not exist.
Local data on etiology and antimicrobial susceptibility are needed to design an effective flowchart. The validity and cost-effectiveness of different approaches can in many situations be estimated from the literature or assessed in special studies.
- Flowcharts should be validated in a field audit to assure efficacy.
Before the introduction of new flowcharts, feasibility and acceptability should be assessed in the given health infrastructure. This will validate acceptable levels of sensitivity and specificity.
- A flowchart will always be a compromise between diagnostic accuracy and technical and financial realities.